Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 9, 2014, Pages

  Gatto, Francesco ^a   Nookaew, Intawat ^a   Nielsen, Jens ^a  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Cancer metabolism; Genome scale metabolic modeling; Renal cancer; Systems biology

Indexed keywords

GLYCEROPHOSPHOLIPID; STAT1 PROTEIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER STAGING; CARBON METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 3P; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METABOLIC REGULATION; NUCLEOTIDE METABOLISM; ONCOGENE; PRIORITY JOURNAL; VHL GENE;

CANCER METABOLISM; GENOME-SCALE METABOLIC MODELING; RENAL CANCER; SYSTEMS BIOLOGY;

BAYES THEOREM; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 3; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; METABOLIC NETWORKS AND PATHWAYS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; STAT1 TRANSCRIPTION FACTOR; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84895833353     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319196111     Document Type: Article

References (39)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144(5):646-674.
2. Ward PS, Thompson CB (2012) Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell 21(3):297-308.
3. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491(7424):364-373, and erratum (2012) 494(7435):130.
4. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85-95.
5. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930):1029-1033.
6. Hu J, et al. (2013) Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol 31(6):522-529.
7. Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274(6):1393-1418.
8. Mardinoglu A, Gatto F, Nielsen J (2013) Genome-scale modeling of human metabolism-a systems biology approach. Biotechnol J 8(9):985-996.
9. Jerby L, Ruppin E (2012) Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin Cancer Res 18(20):5572-5584.
10. Väremo L, Nookaew I, Nielsen J (2013) Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front Physiol 4:92.
11. Lewis NE, Abdel-Haleem AM (2013) The evolution of genome-scale models of cancer metabolism. Front Physiol 4:237.
12. Lewis NE, Nagarajan H, Palsson BO (2012) Constraining the metabolic genotypephenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol 10(4):291-305.
13. Frezza C, et al. (2011) Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477(7363):225-228.
14. Folger O, et al. (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7:501.
15. Mardinoglu A, et al. (2013) Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol Syst Biol 9:649.
16. Creighton CJ, et al. (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499(7456):43-49.
17. Yoshihara K, et al. (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612.
18. Patil KR, Nielsen J (2005) Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc Natl Acad Sci USA 102(8):2685-2689.
19. Väremo L, Nielsen J, Nookaew I (2013) Enriching the gene set analysis of genomewide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res 41(8):4378-4391.
20. Ueland PM, Holm PI, Hustad S (2005) Betaine: A key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med 43(10):1069-1075.
21. Agren R, et al. (2012) Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLOS Comput Biol 8(5):e1002518.
22. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477-2490.
23. Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22(24):4991-5004.
24. Vanharanta S, et al. (2013) Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med 19(1):50-56.
25. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3(3):187-197.
26. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38-47.
27. Jiang Y, et al. (2003) Gene expression profiling in a renal cell carcinoma cell line: Dissecting VHL and hypoxia-dependent pathways. Mol Cancer Res 1(6):453-462.
28. Dranoff G (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4(1):11-22.
29. Danielsson F, et al. (2013) Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model. Proc Natl Acad Sci USA 110(17):6853-6858.
30. Jonasch E, et al. (2012) State of the science: an update on renal cell carcinoma. Mol Cancer Res 10(7):859-880.
31. Cheong H, Lu C, Lindsten T, Thompson CB (2012) Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 30(7):671-678.
32. Robitaille AM, et al. (2013) Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 339(6125):1320-1323.
33. Ben-Sahra I, Howell JJ, Asara JM, Manning BD (2013) Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339(6125):1323-1328.
34. Gerlinger M, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883-892.
35. Singh RB, Amare Kadam PS (2011) Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Urol Oncol 31(7):1333-1342.
36. Brinckmann A, et al. (2002) Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells. Br J Cancer 86(3):449-455.
37. Zambelli F, Prazzoli GM, Pesole G, Pavesi G (2012) Cscan: Finding common regulators of a set of genes by using a collection of genome-wide ChIP-seq datasets. Nucleic Acids Res 40(Web Server issue):W510-W515.
38. Agren R, et al. (2013) The RAVEN toolbox and its use for generating a genomescale metabolic model for Penicillium chrysogenum. PLOS Comput Biol 9(3): e1002980.
39. Pique-Regi R, Cáceres A, González JR (2010) R-Gada: A fast and flexible pipeline for copy number analysis in association studies. BMC Bioinformatics 11:380.